# Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer

> **NCT02848443** · PHASE1 · COMPLETED · sponsor: **Institut de Recherches Internationales Servier** · enrollment: 78 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **DRUG:** Trifluridine/tipiracil hydrochloride (S 95005)
- **DRUG:** Oxaliplatin
- **DRUG:** Bevacizumab
- **DRUG:** Nivolumab

## Key facts

- **NCT ID:** NCT02848443
- **Lead sponsor:** Institut de Recherches Internationales Servier
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2019-08-01
- **Final completion:** 2020-04-09
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2024-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02848443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02848443, "Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02848443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*